University of Naples "Federico II"
Naples, 80100, Italy
NCT Number: NCT04425954
This study evaluates the retinal vascular features using optical coherence tomography angiography in patients that received endoscopic endonasal approach for the removal of an intra-suprasellar pituitary adenoma compressing the optic nerve.
Looking for future studies?
Notify Me45 year–65 year
All sexes
Observational
Naples, 80100, Italy
To investigate the potential role of optical coherence tomography angiography in predicting the postoperative recovery of retinal vascular network of the optic disc in patients before and at 3 months after Endoscopic Endonasal Approach for the removal of an intra-suprasellar pituitary adenoma compressing the optic nerve.
The optical coherence tomography angiography represents a novel and non-invasive diagnostic technique that allows a detailed analysis of retinal vascular features.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Surgical treatment consisted of an endoscopic endonasal approach using a rigid 0-degree endoscope, 18 cm in length and 4 mm in diameter.
Time frame: 48 hours
To evaluate the role of optical coherence tomography angiography in predicting the recovery of the vessel density of the optic disc after surgery, using optical coherence tomography angiography (OCTA). The parameter analyzed by OCTA was the vessel density of the optic disc (percent)
Federico II University
Other
Early Retinal Vascular Modifications After Endoscopic Endonasal Pituitary Surgery: The Role of OCT- Angiography
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00001452
Abnormalities, Multiple, Adrenal Gland Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT02750371
Brain Diseases, Brain Neoplasms
Bordeaux, France
View Trial DetailsNCT07247526
Anxiety Disorders, Brain Diseases
Edirne, Turkey (Türkiye)
View Trial DetailsNCT06826170
Brain Diseases, Brain Neoplasms
Milan, Italy
View Trial Details